K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

被引:254
|
作者
Brink, M
de Goeij, AFPM
Weijenberg, MP
Roemen, GMJM
Lentjes, MHFM
Pachen, MMM
Smits, KM
de Bruïne, AP
Goldbohm, RA
van den Brandt, PA
机构
[1] Maastrict Univ, Dept Epidemiol, NUTRIM, NL-6200 MD Maastricht, Netherlands
[2] Maastrict Univ, Dept Pathol, GROW, Maastricht, Netherlands
[3] TNO Nutr & Food Res, NL-3700 AJ Zeist, Netherlands
关键词
D O I
10.1093/carcin/bgg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 50 条
  • [1] Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study
    Brink, M
    Weijenberg, MP
    de Goeij, AFPM
    Schouten, LJ
    Koedijk, FDH
    Roemen, GMJM
    Lentjes, MHFM
    de Bruïne, AP
    Goldbohm, RA
    van den Brandt, PA
    CARCINOGENESIS, 2004, 25 (09) : 1619 - 1628
  • [2] Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study
    M Brink
    M P Weijenberg
    A F P M de Goeij
    G M J M Roemen
    M H F M Lentjes
    A P de Bruïne
    R A Goldbohm
    P A van den Brandt
    British Journal of Cancer, 2005, 92 : 1310 - 1320
  • [3] Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study
    Brink, M
    Weijenberg, MP
    de Goeij, AFPM
    Roemen, GMJM
    Lentjes, MHFM
    de Bruïne, AP
    Goldbohm, RA
    van den Brandt, PA
    BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1310 - 1320
  • [4] Dietary folate intake and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study
    Brink, M
    Weijenberg, MP
    de Goeij, AFPM
    Roemen, GMJM
    Lentjes, MHFM
    de Bruïne, AP
    van Engeland, M
    Goldbohm, RA
    van den Brandt, PA
    INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (05) : 824 - 830
  • [6] K-ras mutations in incident sporadic colorectal adenomas
    Barry, ELR
    Baron, JA
    Grau, MV
    Wallace, K
    Haile, RW
    CANCER, 2006, 106 (05) : 1036 - 1040
  • [7] Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer:: Results from the Netherlands Cohort Study
    Weijenberg, M. P.
    Aardening, P. W. M.
    de Kok, T. M.
    de Goeij, A. F. P. M.
    van den Brandt, P. A.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2008, 652 (01) : 54 - 64
  • [8] K-ras Mutations and Cetuximab in Colorectal Cancer
    De Roock, Wendy
    Lambrechts, Diether
    Tejpar, Sabine
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 834 - 834
  • [9] Novel mutations in the K-Ras oncogene: implications for personalised medicine in the treatment of colorectal cancer
    Bounds, Rebecca
    Wolf, Helga
    Weidlich, Simone
    Pratt, Norman
    Carey, Francis
    Steele, Robert
    Smith, Gillian
    Wolf, C. Roland
    CANCER RESEARCH, 2009, 69
  • [10] HIGH-FREQUENCY OF K-RAS MUTATIONS IN SPORADIC COLORECTAL ADENOMAS
    MCLELLAN, EA
    OWEN, RA
    STEPNIEWSKA, KA
    SHEFFIELD, JP
    LEMOINE, NR
    GUT, 1993, 34 (03) : 392 - 396